- Home
- SQFT vs HSDT Comparison
SQFT vs HSDT Comparison
Compare SQFT & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- HSDT
- Stock Information
- Founded
- SQFT 1999
- HSDT N/A
- Country
- SQFT United States
- HSDT United States
- Employees
- SQFT N/A
- HSDT N/A
- Industry
- SQFT Real Estate Investment Trusts
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SQFT Real Estate
- HSDT Health Care
- Exchange
- SQFT Nasdaq
- HSDT Nasdaq
- Market Cap
- SQFT 7.7M
- HSDT 6.4M
- IPO Year
- SQFT 2020
- HSDT N/A
- Fundamental
- Price
- SQFT $7.28
- HSDT $23.17
- Analyst Decision
- SQFT
- HSDT Hold
- Analyst Count
- SQFT 0
- HSDT 1
- Target Price
- SQFT N/A
- HSDT N/A
- AVG Volume (30 Days)
- SQFT 947.3K
- HSDT 1.2M
- Earning Date
- SQFT 11-11-2025
- HSDT 11-11-2025
- Dividend Yield
- SQFT N/A
- HSDT N/A
- EPS Growth
- SQFT N/A
- HSDT N/A
- EPS
- SQFT N/A
- HSDT N/A
- Revenue
- SQFT $18,052,597.00
- HSDT $295,000.00
- Revenue This Year
- SQFT $23.63
- HSDT N/A
- Revenue Next Year
- SQFT N/A
- HSDT $75.13
- P/E Ratio
- SQFT N/A
- HSDT N/A
- Revenue Growth
- SQFT N/A
- HSDT N/A
- 52 Week Low
- SQFT $4.19
- HSDT $5.37
- 52 Week High
- SQFT $23.00
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- SQFT 62.88
- HSDT 86.48
- Support Level
- SQFT $5.36
- HSDT $5.78
- Resistance Level
- SQFT $10.47
- HSDT $24.49
- Average True Range (ATR)
- SQFT 0.62
- HSDT 1.88
- MACD
- SQFT 0.34
- HSDT 2.45
- Stochastic Oscillator
- SQFT 45.47
- HSDT 88.18
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.